4//SEC Filing
Newell Joe 4
Accession 0001567619-21-017578
CIK 0001604464other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:35 PM ET
Size
10.7 KB
Accession
0001567619-21-017578
Insider Transaction Report
Form 4
Newell Joe
Chief Tech. Operations Officer
Transactions
- Exercise/Conversion
Common Stock
2021-09-22$12.15/sh+10,500$127,575→ 130,429 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-09-22$17.00/sh−8,375$142,375→ 34,875 totalExercise: $12.15Exp: 2030-02-28→ Common Stock (8,375 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-09-22$17.00/sh−2,125$36,125→ 10,625 totalExercise: $12.15Exp: 2030-02-28→ Common Stock (2,125 underlying) - Sale
Common Stock
2021-09-22$17.00/sh−10,500$178,500→ 119,929 total
Footnotes (2)
- [F1]Transaction pursuant to Rule 10b5-1 Plan adopted September 14, 2020.
- [F2]1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001702457
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 5:35 PM ET
- Size
- 10.7 KB